Related Experiment Video

Updated: Jun 7, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

ASNA-1 activity modulates sensitivity to cisplatin

Oskar Hemmingsson1, Gautam Kao, Maria Still

  • 1Division of Surgery, Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Cancer Research
|October 23, 2010
PubMed

Insights

The nematode Caenorhabditis elegans reveals that the metalloregulated ATPase ASNA-1 (a conserved gene) is crucial for cisplatin resistance in vivo. Targeting ASNA-1 may sensitize cancer cells to platinum-based chemotherapy.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Platinum-based chemotherapy, including cisplatin, is vital for cancer treatment.
  • Cisplatin resistance significantly limits treatment efficacy, necessitating novel therapeutic strategies.
  • Understanding the molecular mechanisms of cisplatin resistance is critical for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of the metalloregulated ATPase ASNA-1 in cisplatin sensitivity using the nematode Caenorhabditis elegans as a model organism.
  • To identify specific ASNA-1 mutations that confer cisplatin hypersensitivity while maintaining essential cellular functions.
  • To explore the conserved function of ASNA-1 and its potential as a therapeutic target for overcoming cisplatin resistance.

Main Methods:

  • Utilized Caenorhabditis elegans as a model to study cisplatin interactions with cellular signaling pathways in vivo.
  • Generated and analyzed null and specific point mutants of the asna-1 gene.
  • Employed structural data from ASNA-1 homologues to guide mutant selection.
  • Assessed cisplatin sensitivity in various genetic backgrounds, including those lacking CEP-1/p53 or apoptosis pathways.
  • Tested the functional conservation of ASNA-1 by substituting the human ASNA1 gene in C. elegans.

Main Results:

  • A null mutation in the asna-1 gene rendered C. elegans hypersensitive to cisplatin.
  • Specific ASNA-1 mutants demonstrated cisplatin sensitivity while preserving insulin signaling.
  • The observed cisplatin hypersensitivity in asna-1 mutants was independent of CEP-1/p53 and apoptosis.
  • Human ASNA1 functionally substituted for the worm asna-1 gene, indicating conserved function.
  • Insulin signaling levels did not affect cisplatin sensitivity in wild-type or asna-1 mutant nematodes.

Conclusions:

  • ASNA-1 plays a significant role in mediating resistance to cisplatin in vivo.
  • C. elegans serves as a valuable model for dissecting cisplatin resistance mechanisms.
  • Targeting ASNA-1 represents a promising strategy for developing novel therapeutics to sensitize cancer cells to cisplatin chemotherapy.

More Related Videos

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...